According to a recent market study published by Growth Market Reports, titled, “Global Throat Lozenges Market by Product Type, By Indication, By Distribution Channel, and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 5,330.7 Million in 2022 and is anticipated to expand at a growth rate of 5.3% by 2031.

Lozenges are small and flavored tablets that are typically designed to dissolve slowly in the mouth. They are used to soothe a sore throat or relieve coughing in the form of medication that is typically absorbed through the mucous membranes of the mouth. Lozenges are available in various flavors and contain ingredients, such as menthol, honey, or various other medications.

Get Sample Report @ https://growthmarketreports.com/request-sample/5925

A throat lozenge is a small medicinal tablet that is meant to dissolve gradually in the mouth. It is referred to as a troche, cachou cough drop, or cough sweet. It aids in cough suppression by lubricating and relaxing sensitive throat tissues. Moreover, it relieves strep throat and sore throats. Benzocaine, an anesthetic, or eucalyptus oil is found in throat lozenges. Non-menthol throat lozenges contain either pectin or zinc gluconate glycine. Dextromethorphan is a widely used ingredient in several types of throat lozenges.

The global throat lozenges market has been segmented in terms of product type, indication, distribution channel, and region. In terms of product type, the global throat lozenges market is split into compressed lozenges, hard candy lozenges, soft lozenges, and chewable lozenges. On the basis of indication, the market is fragmented into oral thrush, sore throat, cough and cold, and others. On the basis of distribution channel, the market is fragmented into pharmacy, online pharmacy, and others. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The COVID-19 pandemic has affected the throat lozenges production and the import & export in various COVID-19-affected countries. The emergency lockdown created a shortage of raw materials and disrupted the supply chain, which reduced consumer demand and impacted the availability of throat lozenges. In the midst of the crisis, each country is taking steps to ensure patient safety. Many healthcare systems have canceled or delayed various medical procedures during the initial wave of the global pandemic in 2020, thereby reducing the sales of a wide range of throat lozenges and decreasing their market values in 2020.

Key Takeaways from the Study:

  • Players in the global throat lozenges market include Bliss GVS Pharma Ltd., Cipla Health Ltd., GSK, iHerb, LLC., Nestlé, Prestige Consumer Healthcare Inc., Procter & Gamble, Reckitt Benckiser Group PLC., Sanofi S.A, and Walgreen Co.

  • The key players in the market are investing in R&D to expand their production facilities and product offerings, facilitating the global expansion of throat lozenges. Furthermore, market participants are strengthening and expanding their market share through a variety of inorganic and organic strategic approaches, such as new product portfolios, contractual deals, mergers and acquisitions, and capital expenditures.

  • Growing prevalence of throat infections and related diseases and increasing healthcare expenditures are expected to create opportunities in the coming years.

  • Based on product type, the market is segmented into compressed lozenges, hard candy lozenges, soft lozenges, and chewable lozenges. The hard candy segment held a significant share of the market in 2022 and is expected to expand at a CAGR of 5.1% during the forecast period.

  • Based on the indication, the market is segmented into oral thrush, sore throat, cough and cold, and others. The sore throat segment is anticipated to expand at a significant CAGR during the forecast period. This growth is attributed to the rising prevalence of strep throat across the globe. For instance, globally, around 600 million people suffer from strep throat every year, many of them children.

  • Based on the distribution channel, the market is segmented into pharmacy, online pharmacy, and others. The pharmacy segment is anticipated to expand at a significant CAGR during the forecast period, owing to the rising number of pharmacies across the globe.

  • Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.  Asia Pacific accounted for a significant share of the market in 2022, due to the growing pediatric and geriatric population, that frequently remains at risk of throat infection, which increases the demand for throat lozenges. Moreover, China is expected to hold a large market share and the market in India is expected to grow steadily in the region during the forecast period.

Report Scope:

Report Metric

Details

Market Value in 2022

US$ 5,330.7 Million

Market Growth Rate (from 2022 to 2031)

5.3%

Historical Data

2016 & 2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By Product Type, By Indication, By Distribution Channel, and By Region

Key Companies Profiled

Bliss GVS Pharma Ltd., Cipla Health Ltd., GSK, iHerb, LLC., Nestlé, Prestige Consumer Healthcare Inc., Procter & Gamble, Reckitt Benckiser Group PLC., Sanofi S.A, and Walgreen Co.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.


Target Audience:

  • Supply-side: Vendor, Manufacturer, Distributors, Supplier, Retailer.

  • Regulatory Side: Concerned government authorities, and other approved regulatory bodies.